Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: A Randomised Controlled Trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Vervloet, Marcia ^a   Van Dijk, Liset ^a   Santen Reestman, Jacqueline ^b   Van Vlijmen, Bas ^b   Bouvy, Marcel L ^c   De Bakker, Dinny H ^a,d  

^a NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^b Mediq Apotheken   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d TILBURG UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

ARTICLE; CLINICAL TRIAL; COMPUTER SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REMINDER SYSTEM;

ADMINISTRATION, ORAL; COMPUTER SYSTEMS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; PATIENT COMPLIANCE; REMINDER SYSTEMS;

EID: 78650978300     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-5     Document Type: Article

References (41)

1. Adherence to long-term therapies. Evidence for action. WHO, Geneva, World Health Organisation 2003
2. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. DT Lau DP Nau, Diabetes Care 2004 27 2149 2153 10.2337/diacare.27.9.2149 15333476
3. Impact of medication adherence on hospitalization risk and healthcare cost. MC Sokol KA McGuigan RR Verbrugge RS Epstein, Med Care 2005 43 521 530 10.1097/01.mlr.0000163641.86870.af 15908846
4. A meta-analysis of the association between adherence to drug therapy and mortality. SH Simpson DT Eurich SR Majumdar RS Padwal RT Tsuyuki J Varney, et al. BMJ 2006 333 15 10.1136/bmj.38875.675486.55 16790458
5. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. PM Ho JS Rumsfeld FA Masoudi DL McClure ME Plomondon JF Steiner, et al. Arch Intern Med 2006 166 1836 1841 10.1001/archinte.166.17.1836 17000939
6. Interventions to enhance patient adherence to medication prescriptions: scientific review. HP McDonald AX Garg RB Haynes, JAMA 2002 288 2868 2879 10.1001/jama.288.22.2868 12472329
7. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. S Kripalani X Yao RB Haynes, Arch Intern Med 2007 167 540 550 10.1001/archinte.167.6.540 17389285
8. Patient adherence to medical treatment: a review of reviews. S van Dulmen E Sluijs L van Dijk D de Ridder R Heerdink J Bensing, BMC Health Serv Res 2007 7 55 10.1186/1472-6963-7-55 17439645
9. Interventions for enhancing medication adherence. RB Haynes E Ackloo N Sahota HP McDonald X Yao, Cochrane Database Syst Rev 2008 D000011 18425859
10. Patient adherence to medical treatment: a meta review. E Sluijs Sv Dulmen Lv Dijk Dd Ridder R Heerdink J Bensing, Utrecht, NIVEL 2006
11. Electronic monitoring of medication adherence: when is high-tech best? K Riekert C Rand, J Clin Psychol Med Settings 2002 9 25 34 10.1023/A:1014131928789
12. Electronic monitoring and counseling to improve medication adherence. MI Rosen MO Rigsby JT Salahi CE Ryan JA Cramer, Behav Res Ther 2004 42 409 422 10.1016/S0005-7967(03)00149-9 14998735
13. Compliance with an oral asthma medication: a pilot study using an electronic monitoring device. KF Chung I Naya, Respir Med 2000 94 852 858 10.1053/rmed.2000.0813 11001076
14. Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. A Winkler AU Teuscher B Mueller P Diem, Swiss Med Wkly 2002 132 379 385 12428192
15. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. E Diaz HB Levine MC Sullivan MJ Sernyak KA Hawkins JA Cramer, et al. J Psychiatry Neurosci 2001 26 325 329 11590972
16. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. ML Bouvy ER Heerdink J Urquhart DE Grobbee AW Hoes HG Leufkens, J Card Fail 2003 9 404 411 10.1054/S1071- 9164(03)00130-1 14583903
17. Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. GE Wetzels PJ Nelemans JS Schouten CD Dirksen WT van der HE Stoffers, et al. Am J Hypertens 2007 20 119 125 10.1016/j.amjhyper.2006.07.018 17261454
18. SMS verbetert therapietrouw bij diabetes type 2. H Chuang P Drost, Pharmaceutisch Weekblad 2003 138 1578
19. Behavioral theories and the problem of compliance. H Leventhal L Cameron, Patient Education and Counseling 1987 10 117 138 10.1016/0738-3991(87)90093-0
20. Intentional and unintentional nonadherence: a study of decision making. AL Wroe, J Behav Med 2002 25 355 372 10.1023/A:1015866415552 12136497
21. Intentional and unintentional nonadherence to antihypertensive medication. KP Lowry TK Dudley EZ Oddone HB Bosworth, Ann Pharmacother 2005 39 1198 1203 10.1345/aph.1E594 15956238
22. Therapietrouw bevorderen is maatwerk. Theoretische en empirische analyse NIVEL. L van Dijk S van Dulmen J Bensing, Pharmaceutisch Weekblad 2007 142 22 25
23. Medicijndoos waarschuwt per sms. Gebruikers waarderen real-time medication monitoring. J-P Biemond IJM Boogers HR Schwietert, Pharmaceutisch Weekblad 2008 43 18 21
24. A systematic review of adherence with medications for diabetes. JA Cramer, Diabetes Care 2004 27 1218 1224 10.2337/diacare.27.5.1218 15111553
25. Improving oral pharmacologic treatment and management of type 2 diabetes. GE Dailey III, Manag Care 2004 13 41 47 15004930
26. Oral antidiabetic medication adherence and glycemic control in managed care. Y Rozenfeld JS Hunt C Plauschinat KS Wong, Am J Manag Care 2008 14 71 75 18269302
27. New findings about patient adherence to prescribed drug dosing regimens: an introduction to pharmionics. J Urquhart B Vrijens, Eur J Hosp Pharm Sci 2005 11 103 106
28. What is meant by intention to treat analysis? Survey of published randomised controlled trials. S Hollis F Campbell, BMJ 1999 319 670 674 10480822
29. A framework for mobile healthcare answers to chronically ill outpatient non-adherence. M Cocosila N Archer, Inform Prim Care 2005 13 145 152 15992499
30. Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion. S van Dulmen E Sluijs L van Dijk D de Ridder R Heerdink J Bensing, BMC Health Serv Res 2008 8 47 10.1186/1472-6963-8-47 18304337
31. Prediction of diltiazem plasma concentration curves from limited measurements using compliance data. A Rubio C Cox M Weintraub, Clin Pharmacokinet 1992 22 238 246 10.2165/00003088-199222030-00006 1559314
32. Do we need full compliance data for population pharmacokinetic analysis? P Girard LB Sheiner H Kastrissios TF Blaschke, J Pharmacokinet Biopharm 1996 24 265 282 10.1007/BF02353671 8970015
33. The impact of compliance in pharmacokinetic studies. B Vrijens E Goetghebeur, Stat Methods Med Res 1999 8 247 262 10.1191/096228099669221405 10636337
34. Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models. B Vrijens E Tousset R Rode R Bertz S Mayer J Urquhart, J Clin Pharmacol 2005 45 461 467 10.1177/0091270004274433 15778427
35. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. DI Velligan M Wang P Diamond DC Glahn D Castillo S Bendle, et al. Psychiatr Serv 2007 58 1187 1192 10.1176/appi.ps.58.9.1187 17766564
36. When does nonadherence matter? Section 2, Concepts and terminology. R Horne, Corcordance, adherence and compliance in medicine taking London: National Coordinating Centre for NHS Service Delivery and Organisation 2005
37. Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. L van Dijk ER Heerdink D Somai S van Dulmen EM Sluijs DT de Ridder, et al. BMC Health Serv Res 2007 7 51 10.1186/1472-6963-7-51 17425792
38. The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. BL van Wijk OH Klungel ER Heerdink A de Boer, J Hypertens 2004 22 1831 1837 10.1097/00004872-200409000- 00029 15311113
39. Het discriminerend vermogen van de CQ-index Farmaceutische Zorg. M Van Greuningen M Vervloet L Van der Hoek L van Dijk, Utrecht, NIVEL 2008
40. The association between diabetes metabolic control and drug adherence in an indigent population. JM Schectman MM Nadkarni JD Voss, Diabetes Care 2002 25 1015 1021 10.2337/diacare.25.6.1015 12032108
41. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. DB Lawrence KR Ragucci LB Long BS Parris LA Helfer, J Manag Care Pharm 2006 12 466 471 16925454